Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03069430 · ClinicalTrials.gov registry record

A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I

A clinical trial of Anemia, Sickle Cell, sponsored by Medical University of South Carolina.

Completed
Registry status
44
Enrollment target
1
Study location

NCT03069430 is a study of Anemia, Sickle Cell that has completed, run by Medical University of South Carolina. The registered enrollment target is 44 participants, below the 116-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03069430, a study of Anemia, Sickle Cell, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
44 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted to test an intervention for children and adolescents ages 8-17 years with sickle cell disease and their families. In the first phase of this study, key informant interviews are being conducted with health care providers and children ages 8-17 with sickle cell disease and their primary caregivers. Participants are asked to review the intervention and provide feedback that will inform revision to the intervention.

Conditions Studied

Interventions

  • BEHAVIORAL SELFY (Self Management for Youth with SCD)

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2016-08-01
Est. Completion 2017-03-31

What the Registry Record Tells You About NCT03069430

The ClinicalTrials.gov registry entry for NCT03069430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (62% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 1 intervention - of which SELFY (Self Management for Youth with SCD) is the first listed.

NCT03069430 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03069430 about?

NCT03069430 is a clinical study titled "A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I". This study is being conducted to test an intervention for children and adolescents ages 8-17 years with sickle cell disease and their families. In the first phase of this study, key informant interviews are being conducted with health care providers and children ages 8-17 with sickle cell disease an...

What is the current status of trial NCT03069430?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2016-08-01. Estimated completion is 2017-03-31.

What conditions does trial NCT03069430 study?

This clinical trial studies the following conditions: Anemia, Sickle Cell.

What interventions are being tested in trial NCT03069430?

The interventions under investigation include: SELFY (Self Management for Youth with SCD) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03069430?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03069430 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia, Sickle Cell

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.